Your Pathway to Development

At MaxCyte, we understand that cell therapy development demands more than cutting-edge technology-it requires a trusted partner committed to your success at every step.

Our partnership model supports every phase from discovery to commercialization, offering scalable solutions, regulatory support, and cell engineering optimization. Together, we can accelerate therapies to market, ensuring a transformative impact on patients worldwide.

Pathway-development

MaxCyte's Partnership Model: Your Pathway to Development

MaxCyte empowers cell therapy developers with a proven partnership model tailored to your needs. From discovery to commercialization, we provide scalable technology, regulatory support, and unmatched cell engineering optimization.

Our non-viral cell engineering solutions accelerate development timelines and can drive cost savings of up to $12M. Trusted in 70+ clinical trials, and the only commercial-stage non-viral therapy, MaxCyte ensures scalability and compliance while mitigating risks.

Let us guide your development journey through every phase, from achieving early clinical success to global market entry.

Explore how MaxCyte can support your pathway to success.

MaxCyte Best in Class Technology

MaxCyte pushes the boundaries in cell therapy development with cutting-edge, non-viral engineering technology

The ExPERT™ GTx™ Electroporation Instrument has consistently supported clinical and commercial manufacturing with seamless scalability.

  • Robust transfection process ensures consistent, reproducible results across diverse donors and manufacturing sites.
  • Compact design minimizes space requirements in manufacturing suites.
  • Simple instrument and processing assembly setup enable seamless tech transfer from process development to manufacturing, and minimizes operator-related errors.
  • Multiple pre-optimized protocols for over 80 cell types minimize time spent in optimization of electroporation parameters.
  • Fast processing time (8 mL per minute) minimizes impact in cell health.

 

career-rmeeting-img@2x

Your Pathway to Development

SPL Graphics_Icon-pink-arrow 1
Discovery

Gain direct access to MaxCyte experts for on-site electroporation optimization and seamless scaling to advance your research.

SPL Graphics 012225_Icon-purple-arrow 1
Clinical Manufacturing

Receive seamless tech transfer support ensuring real-time solutions for clinical production challenges.

SPL Graphics_Icon-cyan-arrow 1
Commercial

Benefit from lifetime support with 24/7 assistance, quality assurance, regulatory support, and on-demand MaxCyte insights for production success.

SPL Graphics_three rings-pathway

Your License, Your Advantage

A strategic platform license underpins our partnership model, empowering your pathway to cell and gene therapy development. With tailored flexibility, regulatory expertise, and cutting-edge technology, the license ensures access to our robust IP and know-how, enabling a seamless progression from clinical development to commercialization.

Discover how MaxCyte's license delivers flexibility and long-term value for your programs.

Ready to learn how we can streamline your cell therapy development?

Accelerate Your Pathway to Development - Contact Our Business Development Team Today

Ask the ExPERT